A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.

Clinical trial NCT04019561 · COMPLETED

Trial details

NCT number: NCT04019561
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)

Start date: 2019-09-23
Primary completion: 2021-05-06
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.